La Crosse Method Practice Protocol

June 15, 2016

Hindsight on childhood allergies

By Beth Davidson, Allergychoices

There are so many memories from my childhood about ear infections, sinus infections, migraines, hives, stomach aches, and the list goes on. I had friends and cousins with severe allergies who had “traditional” allergy symptoms – itchy eyes, stuffy nose, rashes, etc. But me? No way could my health problems have […]

More »

, , , , , ,

February 24, 2016

Eosinophilic Esophagitis and Sublingual Immunotherapy: Our Experience

Author: Mary Morris, MD, ABIM

More frequently we hear about patients suffering with Eosinophilic Esophagitis (e-o-sin-o-FILL-ik uh-sof-uh-JIE-tis, or EoE) and concerns about using the La Crosse Method™ Protocol for allergy drop treatment where this condition is noted.

Eosinophilic Esophagitis is a build-up of white blood cells (eosinophils) in the lining of the tube […]

More »

, ,

September 23, 2015

Glycerin: The Ideal Diluent for Sublingual Immunotherapy Allergy Drops

Author: Mike Kachel, RPh, Allergychoices Pharmacy Director

Using the La Crosse Method Protocol at Allergychoices, we believe that a critical point of under the tongue delivery of the antigens for sublingual immunotherapy is the vehicle in which the antigens are suspended. Our nearly 45 year history with custom sublingual immunotherapy allergy […]

More »

, , , ,

September 8, 2015

Why Sublingual Immunotherapy Works: Understanding the mechanism

Author: Mary Morris, MD, ABIM

Drops under the tongue? How is that is going to help my allergies? I used to hear this daily from my patients and now there seems to be a seismic shift in what patients know about sublingual immunotherapy, or allergy drops, and their success in allergy treatment.

Sublingual immunotherapy […]

More »

, , ,

August 25, 2015

La Crosse Method Reviewed

Author: Mary Morris, MD, ABIM

In recent years, sublingual immunotherapy has continued to gain acceptance and understanding, leading to its international recognition as a viable alternative to subcutaneous injection for allergy in both adults and children.1 With the recent FDA approval of single antigen sublingual immunotherapy tablets, even more physicians are considering, referring or […]

More »